Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 18
Review
Once-Daily Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults and Adolescents Aged 12 Years and Over: A Short Review of Current Clinical Perspectives
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,071 | Dovepress* | 6,383+ | 382 | 6,765 | |
| PubMed Central* | 2,688 | 417 | 3,105 | ||
| Totals | 9,071 | 799 | 9,870 | ||
| *Since 13 April 2022 | |||||
View citations on PubMed Central and Google Scholar